"We demonstrate that patients with metastatic disease stayed on therapy longer—a median of 9 months vs 7 months for the non-metastatic patients," says Rana R. McKay, MD, FASCO. Overall, data from the ...

A panelist discusses how benign prostatic hyperplasia (BPH) treatment has evolved to include a spectrum of minimally invasive and surgical interventions, ranging from emerging technologies like ...

"A lot of people are using [single-use ureteroscopes] nowadays, and part of it is because it really enhances our ability to provide guaranteed care, because we don't have to rely on the reusability of ...

Sixty percent of patients with baseline UUI experienced complete resolution at one year post-surgery, independent of sling type. De novo UUI was observed in 11% of patients, with colpocleisis ...

Gepotidacin, 177Lu-PSMA-617, and durvalumab received FDA approvals, marking significant advancements in urology treatment paradigms. UGN-102's NDA decision for LG-IR-NMIBC is expected by June 13, 2025 ...

"We see the overall survival, whether it is [in] all-comers, in HRR gene mutation-positive patients, or in HRR gene [mutation]-negative patients or [those] who did not have mutations, the overall ...

Experts discuss how they communicate various treatment options for non–muscle-invasive bladder cancer (NMIBC) with patients and health care professionals.

Experts share their initial impressions of the available data on immunotherapies, including PD-L1 inhibitors durvalumab and sasanlimab, being evaluated in bacille Calmette-Guérin (BCG)–unresponsive ...

"We have communicated with Solventum, who makes this software, and they have made changes based on our feedback," says Timothy D. Lyon, MD. Investigators recently identified key concerns in the US ...

ProACT is recommended for non-radiated patients with stress urinary incontinence, offering adjustability for mild to severe cases. The procedure combines cystoscopy and fluoroscopy, with postoperative ...

"This is another tool in our armamentarium to treat muscle-invasive bladder cancer and represents an advance compared to where we've been over the past few decades," says Matthew D. Galsky, MD. The ...

"This study was an investigator initiated study, and what they wanted to do was a randomized trial for large prostates, so 80 to 180 grams, between Aquablation and prostate enucleation," says Naeem ...